LabPulse.com staff writersProteomicsBiodesix reports doubling lung nodule testing activityBiodesix has reported that its lung diagnostic test distribution and revenue has increased over 50% compared to this time last year.May 10, 2024Mergers & AcquisitionsMyriad Genetics reorganizes EU operations, sells EndoPredict businessPrecision medicine company Myriad Genetics has signed an agreement to sell its EndoPredict business to French IVD and life sciences firm Eurobio Scientific.May 9, 2024ConcussionDanaher launches collaboration with Johns Hopkins University on TBI diagnosticsDanaher has launched a partnership with Johns Hopkins University aimed at developing new traumatic brain injury (TBI) diagnostics.May 9, 2024LawsuitGerman court rules patent invalid in 10x infringement suit against NanoStringThe German Federal Patent Court has ruled invalid the German part of a patent at the heart of a lawsuit brought by 10x Genomics against NanoString Technologies, now a Bruker subsidiary.May 8, 2024PCRQiagen partners with FBI on forensics assayQiagen has announced a collaboration with the FBI to develop a new assay to improve DNA quantification for use in forensics and human identification.May 8, 2024ImmunoassaysUniversity of Florida researchers develop CRISPR-based assay for HPV detectionResearchers at the University of Florida have developed a testing method that utilizes CRISPR gene-editing technology to detect HPV in blood or saliva samples that could promote earlier cervical cancer detection.May 7, 2024FDA ClearanceGeneoscopy receives FDA approval for CRC screening testGeneoscopy announced that the U.S. Food and Drug Administration (FDA) has approved ColoSense, the firm's noninvasive multitarget stool RNA colorectal cancer (CRC) screening test.May 7, 2024FinancingKarius raises $100M in series C fundingDiagnostics firm Karius has secured $100 million in series C funding in a recent financing round.May 6, 2024CollaborationNovo Nordisk Foundation, Wellcome, Gates Foundation to partner on global health challengesThe Novo Nordisk Foundation, Wellcome, and the Bill & Melinda Gates Foundation have announced a collaboration to support scientific research and development for accessible solutions to global health challenges.May 6, 2024Trends and FinanceCue Health to cut 230 jobs in restructuring planIn a filing with the U.S. Securities and Exchange Commission, Cue Health said it intends to cut 230 jobs, 49% of its workforce, as part of a cost-reduction plan the firm is implementing.May 3, 2024Previous PagePage 2 of 343Next PageTop StoriesFDA ClearanceAmgen gets FDA approval for small cell lung cancer therapyAmgen announced on Thursday that the U.S. Food and Drug Administration (FDA) has approved its therapy tarlatamab, to be marketed under the name Imdelltra, for the treatment of extensive-stage small cell lung cancer (ES-SCLC).Artificial IntelligenceBacklog of unresolved medical diagnoses leads to new method for clinical exome reanalysisStockT2 Biosystems to sell $8M in stock in private placementFDA Warning LetterFDA issues warning for Cue Health COVID-19 testsSponsor ContentVisit our Molecular Diagnostics Community